News | January 22, 2025
Catalent to further expand Galapagos’ decentralized CAR-T manufacturing network in US
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales of approximately $19.7 million
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
Jemperli plus chemotherapy is the only immuno-oncology-based treatment to show statistically significant and clinically meaningful OS benefit in the overall population
This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
This is the second Ready-To-Use Infusion bag (RTU Bags) ANDA drug product approved for Caplin Steriles
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
Subscribe To Our Newsletter & Stay Updated
